Chengdu Easton Biopharmaceuticals Co.
Latest round
- Series A
Last raised
- Jul 2015
Total raised
- Undisclosed
Investors
- 2
About Chengdu Easton Biopharmaceuticals Co.
, Ltd operates as a pharmaceutical company dedicated to providing chemical drugs. It has branch-offices in Shanghai and Xizang. The company has 115 patents, including 106 invention patents. It also acquired certifications such as US FDA and EU EMA certification. Easton Biopharmaceuticals has 426 R&D employees. In May 2016, Easton Biopharmaceuticals was listed on the New Third Board. In September 2020. Easton Biopharmaceuticals was listed on the Shanghai Stock Exchange Sci-Tech Innovation Board. The company mainly provides preparation products and active pharmaceutical ingredients. The main products include moxifloxacin hydrochloride, fluoxetine maleate, sodium ibandronate injection, and vecuronium bromide for injection. The preparation products cover the fields of cardiovascular and cerebrovascular diseases, oncology, endocrinology, central nervous system, and other fields. Easton Biopharmaceuticals has industrialized nearly 30 chemical active pharmaceutical products, and more than 10 chemical active pharmaceutical products have been exported to the international market.52 million.
Who invested in Chengdu Easton Biopharmaceuticals Co.
2 investors across 1 round
See all investors in Chengdu Easton Biopharmaceuticals Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 7, 2015
Amount
Undisclosed
Investors
Questions about Chengdu Easton Biopharmaceuticals Co.
Who invested in Chengdu Easton Biopharmaceuticals Co.?
Chengdu Easton Biopharmaceuticals Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chengdu Easton Biopharmaceuticals Co. raised?
Chengdu Easton Biopharmaceuticals Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Chengdu Easton Biopharmaceuticals Co. last raise money?
Chengdu Easton Biopharmaceuticals Co.'s most recent round on record is a Series A, in Jul 2015.
What does Chengdu Easton Biopharmaceuticals Co. do?
, Ltd operates as a pharmaceutical company dedicated to providing chemical drugs.
Where is Chengdu Easton Biopharmaceuticals Co. headquartered?
Chengdu Easton Biopharmaceuticals Co. is headquartered in Chengdu, China.
Which VCs invest in companies like Chengdu Easton Biopharmaceuticals Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Chengdu Easton Biopharmaceuticals Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Chengdu Easton Biopharmaceuticals Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.